Printer Friendly
The Free Library
4,488,626 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Citigroup, Biogen Idec Among Big Movers in the Stock Market


Stocks that were moving substantially or trading heavily Monday on the New York Stock Exchange and Nasdaq Stock Market:

NYSE

Citigroup Inc., down $1.67 at $46.20.

Third-quarter profits at the biggest U.S. bank fell 57 percent after it took a hit of more than $3 billion in mortgage-backed security losses, leveraged debt write-downs, and fixed-income trading losses.

SLM Corp., down $2.10 at $46.35.

An investor group that seeks to walk way from a $25 billion buyout of the student lender, better known as Sallie Mae, told a Delaware court it should not have to pay the $900 million breakup fee stipulated in the agreement.

Medtronic Inc., down $6.75 at $49.58.

The medical device maker is stopping distribution of wires that connect some of its defibrillators to patients' hearts after learning they may have contributed to five deaths.

NASDAQ

Biogen Idec Inc., up $13.70 at $83.13.

The biotechnology company said it may sell itself and has attracted some interest from potential buyers.

Force Protection Inc., down $1.72 at $22.23.

The armored vehicle maker found material weaknesses in accounting system, according to a filing with the Securities and Exchange Commission.

The Children's Place Retail Stores Inc., up 99 cents at $24.91.

Ezra Dabah, the former chief executive and a current director of the retailer is considering making a bid for the retailer, according to an SEC filing.

Copyright 2007 AP Features
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright (c) Mochila, Inc.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Author:Staff
Publication:AP Features
Date:Oct 15, 2007
Words:225
Previous Article:Danaher to buy Ore. pioneer Tektronix for $2.85 billion
Next Article:GM's agreement with UAW to set up retiree health care fund may accelerate trend



Related Articles
Biogen Idec doubles its 4th-quarter profit on sales of Rituxan and Avonex
Biogen Idec doubles its 4th-quarter profit, but misses Street estimate
Biogen Idec exploring potential sale of company
Biogen Idec exploring potential sale
Citigroup, Biogen Idec Among Big Movers in the Stock Market
Biogen Idec 3Q profit, revenue fall, miss Wall Street expectations
Amid possible buyout, Biogen Idec misses Street's 3Q expectations
Amid possible buyout, Biogen Idec misses Street's 3Q expectations
Biogen says it plans to stay independent
Biogen Idec shares plunge 28 percent after it says it's ending search for potential buyer

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles